Altrova Health Inc. ROVA
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 718.75% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 718.75% | -- | -- | -- | -- |
| Cost of Revenue | 1,473.81% | -- | -- | -- | -- |
| Gross Profit | 267.14% | -- | -- | -- | -- |
| SG&A Expenses | 19.69% | -8.03% | -34.26% | -68.99% | -62.04% |
| Depreciation & Amortization | 5,320.00% | -- | -- | -340.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.12% | -1.93% | -32.30% | -67.97% | -61.91% |
| Operating Income | -20.38% | 8.90% | 33.57% | 68.63% | 62.23% |
| Income Before Tax | -168.15% | -108.60% | -57.30% | 15.89% | 84.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -168.15% | -108.60% | -57.30% | 15.89% | 84.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -168.15% | -108.60% | -57.30% | 15.89% | 84.44% |
| EBIT | -20.38% | 8.90% | 33.57% | 68.63% | 62.23% |
| EBITDA | -18.39% | 10.25% | 34.12% | 68.67% | 47.96% |
| EPS Basic | -62.88% | 1.04% | 27.82% | 60.71% | 90.85% |
| Normalized Basic EPS | 31.33% | 58.68% | 67.11% | 81.88% | 90.60% |
| EPS Diluted | -62.88% | 1.04% | 27.82% | 60.71% | 90.85% |
| Normalized Diluted EPS | 31.33% | 58.68% | 67.11% | 81.88% | 90.60% |
| Average Basic Shares Outstanding | 57.79% | 102.18% | 109.40% | 85.79% | 81.03% |
| Average Diluted Shares Outstanding | 57.79% | 102.18% | 109.40% | 85.79% | 81.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |